|
1
|
Shamblin WR, ReMine WH, Sheps SG and
Harrison EG Jr: Carotid body tumor (Chemodectoma),
Clinicopathologic analysis of ninety cases. Am J Surg. 122:732–739.
1971. View Article : Google Scholar
|
|
2
|
Fruhmann J, Geigl JB, Konstantiniuk P and
Cohnert TU: Paraganglioma of the carotid body: Treatment strategy
and SDH-gene mutations. Eur Vasc Endovasc Surg. 45:431–436. 2013.
View Article : Google Scholar
|
|
3
|
Sajid MS, Hamilton G and Baker DM: A
multicenter review of carotid body tumor management. Eur J Vasc
Endovasc Surg. 34:127–130. 2007. View Article : Google Scholar
|
|
4
|
Lee JH, Barich F, Karnell LH, Robinson RA,
Zhen WK, Gantz BJ and Hoffman HT; American College of Surgeons
Commission on Cancer, ; American Cancer Society, : National cancer
data base report on malignant paragangliomas of the head and neck.
Cancer. 94:730–737. 2002. View Article : Google Scholar
|
|
5
|
Zhang WC, Cheng JP, Li Q, Zhang L, Wang XD
and Anniko M: Clinical and pathological analysis of malignant
carotid body tumor: A report of nine cases. Acta Otolaryngol.
129:1320–1325. 2009. View Article : Google Scholar
|
|
6
|
Hall TC, Renwick P and Stafford ND:
Recurrent familial malignant carotid body tumour presenting with
lymph node metastasis: Case report and review of diagnosis and
management of familial carotid body tumours. J Laryngol Otol.
124:1344–1346. 2010. View Article : Google Scholar
|
|
7
|
Nishijima H, Asakage T and Sugasawa M:
Malignant carotid body tumor with systemic metastases. Ann Otol
Rhinol Lalyngol. 120:381–385. 2011. View Article : Google Scholar
|
|
8
|
Offergeld C, Brase C, Yaremchuk S, Mader
I, Rischke HC, Gläsker S, Schmid KW, Wiech T, Preuss SF, Suárez C,
et al: Head and neck paragangliomas: Clinical and molecular genetic
classification. Clinics(Sao Paulo). 67 Suppl 1:S19–S28. 2012.
View Article : Google Scholar
|
|
9
|
Burnichon N, Rohmer V, Amar L, Herman P,
Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G,
Chabolle F, et al: The succinate dehydrogenase genetic testing in a
large prospective series of patients with Paragangliomas. J Clin
Endocrinol Metab. 94:2817–2827. 2009. View Article : Google Scholar
|
|
10
|
Neumann HP, Erlic Z, Boedeker CC, Rybicki
LA, Robleda M, Hermsen M, Schiavi F, Falcioni M, Kwok P, Bauters C,
et al: Clinical predictors for germline mutations. in head and neck
paraganglioma patients: Cost reduction strategy in genetic
diagnostic process as fall-out. Cancer Res. 69:3650–3656. 2009.
View Article : Google Scholar
|
|
11
|
Astuti D, Latif F, Dallolv A, Dahia PL,
Douglas F, George E, Sköldberg F, Husebye ES, Eng C and Maher ER:
Gene mutations in the succinate dehydrogenase subunit SDHB cause
susceptibility to familial pheochromocytoma and to familial
paraganglioma. Am J Hum Genet. 69:49–54. 2001. View Article : Google Scholar
|
|
12
|
Kirmani S and Young WF: Hereditary
Paraganglioma-Pheochromocytoma Syndromes. Gene Reviews = Source
GeneReviews® [Internet]. Adam MP, Ardinger HH, Pagon RA,
Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A and
Ledbetter N: University of Washington; Seattle: 2008 Nov 6–2014
|
|
13
|
Unlü Y, Becit N, Ceviz M and Koçak H:
Management of carotid body tumors and familial paragangliomas:
Review of 30 years' experience. Ann Vasc Surg. 23:616–620. 2009.
View Article : Google Scholar
|
|
14
|
O'Neill S, O'Donnell M, Harkin D, Loughrey
M, Lee B and Blair P: A 22-year northern Irish experience of
carotid body tumours. Ulster Med J. 80:133–140. 2011.
|
|
15
|
Nazari I, Moghaddam FA, Zamani MM and
Salimi J: Clinical characteristics and remedies in 45 Iranians with
carotid body tumors. Acta Med Iran. 50:339–343. 2012.
|
|
16
|
Luna-Ortiz K, Rascon-Ortiz M,
Villavicencio-Valencia V, Granados-Garcia M and Herrera-Gomez A:
Carotid body tumors: Review of a 20-year experience. Oral Oncol.
41:56–61. 2005. View Article : Google Scholar
|
|
17
|
Sridhara SK, Yener M, Hnna EY, Rich T,
Jimenez C and Kupferman ME: Genetic testing in head and neck
paraganglioma: Who, what and why? J Neurol Surg B Skull Base.
74:236–240. 2013. View Article : Google Scholar
|
|
18
|
Ogawa K, Shiga K, Saijo S, Ogawa T, Kimura
N and Horii A: A novel G106D alteration of the SDHD gene in a
pedigree with familial paraganglioma. Am J Med Genet A.
140:2441–2446. 2006. View Article : Google Scholar
|
|
19
|
Kim ES, Kim SY, Mo EY, Jang DK, Moon SD
and Han JH: Novel germline SDHD mutation in a patient with
recurrent familial carotid body tumor and concomitant
pheochromocytoma. Head neck. 36:E131–E135. 2014. View Article : Google Scholar
|
|
20
|
Wang CP, Chen TC, Chang YL, Ko JY, Yang
TL, Lo FY, Hu YL, Chen PL, Wu CC and Lou PJ: Common genetic
mutations in the start codon of the SDH subunit D gene among
Chinese families with familial head and neck paragangliomas. Oral
Oncol. 48:125–129. 2012. View Article : Google Scholar
|
|
21
|
Kupferman ME and Hanna EY: Paragangliomas
of the head and neck. Curr Oncol Rep. 10:156–161. 2008. View Article : Google Scholar
|
|
22
|
Power AH, Bower TC, Kasperbauer J, Link
MJ, Oderich G, Cloft H, Young WF Jr and Gloviczki P: Impact of
preoperative embolization on outcomes of carotid body tumor
resections. J Vasc Surg. 56:979–989. 2012. View Article : Google Scholar
|
|
23
|
Torrealba JI, Valdés F, Krämer AH, Mertens
R, Bergoeing M and Mariné L: Management of carotid bifurcation
tumors: 30-year experience. Ann Vasc Surg. 34:200–205. 2016.
View Article : Google Scholar
|
